About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Decreasing Nightmares in Adults With Narcolepsy | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNANCT06383806

Decreasing Nightmares in Adults With Narcolepsy

The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with narcolepsy. All participants will receive the treatment and will comple...

Lead sponsor: University of Utah•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Jennifer Mundt, PhD

CONTACT

801-646-8287 DAWNstudy@utah.edu

Sponsors

Lead Sponsor

University of Utah

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•PARTICIPANTS WITH NARCOLEPSY/NIGHTMARES
•Diagnosis of narcolepsy type 1 or narcolepsy type 2
•Nightmare frequency of ≥1 times per week
•Age 18 or older
•Able to speak, read, and write in English
•Live in the United States
•Sleep and psychiatric medications stable for ≥ 1 month and willing to keep medications stable for the duration of the study
•Live with a romantic partner who meets the above criteria and has agreed to participate in the study
•Age 18 or older
•Able to speak, read, and write in English
•Live in the United States

Exclusion Criteria

•Currently engaged in trauma- or sleep-related psychotherapy
•Previous behavioral treatment for nightmares
•Medical, psychiatric, or cognitive condition which would interfere with ability to engage in the treatment
•Untreated moderate-severe sleep apnea
•PARTICIPANTS WHO ARE PARTNERS OF SOMEONE WITH NARCOLEPSY

Related studies

RECRUITINGPhase 3

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

NCT07502443 · Narcolepsy Type 2

Epidemiology of Narcolepsy Type 1 and Type 2 in Spain

NCT07299097 · Narcolepsy Type 1, Narcolepsy Type 2

RECRUITINGPhase 3

A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

NCT07363720 · Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy

RECRUITINGPhase 2/3

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

NCT05816382 · Narcolepsy Type 1

RECRUITINGPhase 2/3

A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

NCT06767683 · Narcolepsy Type 1, Narcolepsy Type 2, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 10, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment80

Start dateApr 2026

Last updatedMar 10, 2026

Condition

Narcolepsy Narcolepsy Type 1 Narcolepsy With Cataplexy Narcolepsy Without Cataplexy Nightmare+1 more

Locations shown

University of Utah

Salt Lake City, Utah

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 10, 2026Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions